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Abstract
Background: Acute urinary retention (AUR) is a common urological problem. We have observed
a growing list of patients on indwelling bladder catheter awaiting surgery after AUR. This study was
aimed at identifying the health, financial and quality of life (QoL) implications of prolonged use of
indwelling catheter in these patients
Methods: We review the side-effects, QoL and cost of changing an indwelling catheter among
patients who were on the waiting list for definitive surgery after AUR. All the 62 patients who
presented to weekly catheter clinic for change of the indwelling catheter were recruited over a 3
– week period into the study.
Results: The mean age of the patients was 57.5 years and the mean catheter use time was 23
months. The aetiology of AUR was BPH in 40 (64%) and urethral trauma in 16 (28.4%) of the
patients. The common side effects of prolonged catheterization included urethral/suprapubic pain,
bleeding per urethram, loss of dignity, loss of job or being out of school, lack of sexual intercourse,
pericatheter leakage of urine and recurrent urinary tract infection. The cost of change of the
indwelling catheter to the patient each time ranged from 460.00 – 2500.00 Naira (averaged 789.67
Naira). The total annual cost for the change of indwelling catheter after AUR in our catheter clinic
was estimated to be 7,350,000.00 Naira (58,800 US dollars) with 1,890,000.00 Naira (15,120 US
dollars) being the cost borne by the patients per annum and the rest being government subsidy.
Fifty-three (85.5%) patients described that they were unhappy. There was a significant correlation
between QoL and the presence of pain (p = 0.015) and bleeding (p = 0.042) associated with the
presence of an indwelling catheter.
Conclusion: The need to have an indwelling catheter for a prolonged period after AUR is a painful
experience and associated with several side-effects. This has a significant negative effect on the
patients' QoL and constitutes a significant financial burden to the patients and the government. We
suggest that measures should be put in place to reduce the waiting time for surgery and therefore
the catheterization time among the patients with AUR.
Published: 26 September 2007
BMC Urology 2007, 7:16 doi:10.1186/1471-2490-7-16
Received: 30 December 2006
Accepted: 26 September 2007
This article is available from: http://www.biomedcentral.com/1471-2490/7/16
© 2007 Ikuerowo et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4
(page number not for citation purposes)
BMC Urology 2007, 7:16 http://www.biomedcentral.com/1471-2490/7/16Background
Acute urinary retention (AUR) is a common urological
emergency characterized by a sudden and painful inabil-
ity to pass urine. It is estimated that 10% of men in their
seventies and a third in their eighties will have AUR within
the next five years [1,2]. AUR is an important public
health issue. It has a significant impact on the patient's
health-related QoL and is associated with a substantial
economic burden [1,2].
AUR may be caused by: a greater resistance to the flow of
urine due to mechanical or dynamic obstruction, bladder
over-distension or neuropathic disease [1]. The immedi-
ate treatment of AUR consists of bladder decompression,
either by a urethral catheter or a suprapubic catheter [1,2].
In our practice, suprapubic cystostomy is usually reserved
for patients in whom urethral catheterization is contrain-
dicated or has failed. The subsequent management
depends on the cause of the AUR. The patients often have
to remain on a long waiting list for the definitive surgical
procedure [3].
The aim of the study was to describe the problems associ-
ated with the prolonged use of indwelling catheter as well
as the cost implication of changing these catheters among
patients who previously had AUR while awaiting defini-
tive surgical treatment in our institution.
Methods
We evaluated all the patients who presented for a change
of their indwelling catheter at the weekly catheter clinic of
Lagos State University Teaching Hospital, Ikeja, Lagos,
Nigeria, over a 3-week period in the month of May, 2006.
Approval for the study was obtained from our institution
review board and the patients gave their consent after the
study had been explained to them. The patients have been
on indwelling bladder catheter following AUR. Our
patients usually present to the catheter clinic at a regular
interval of 3 weeks for a change of the indwelling catheter.
Therefore the study was limited to a 3-week period so as
to avoiding re-evaluating patients who had already been
seen previously. A questionnaire was designed and com-
pleted for all the patients. Initial validation of the ques-
tionnaire was carried out on 10 patients before it was
applied. The house physician assisted the patients who
had difficulty completing the questionnaire. Information
obtained included the patients' biodata, clinical diag-
noses, duration of catheter use, reason for and effect of
prolonged catheter use, estimated cost of change of cathe-
ter and the patients' perceived QoL.
The cost of change of catheter was estimated by the
patients. This included the cost of procurement of all the
materials needed for the catheter change, the cost of drugs
prescribed in relation to the catheter change and the cost
of transportation to and from the hospital. The patients
did not pay any service charge as this is taken care of by
the subsidy from the government.
As regards the patients' perceived QoL, the question ''How
do you feel about your life regarding the need to use an
indwelling bladder catheter while awaiting operation?"
was asked. The responses were ''sad", ''indifferent", or
''happy". We did not use the QoL measure in the Interna-
tional Prostate Symptoms Score questionnaire because of
the difficulty in interpreting some of the responses in our
local languages. Further information was also obtained
from the patients' notes.
The data was evaluated using the SPSS 14.0 software for
Windows. Comparison of means was carried out using the
Student's t-test and correlations of parametric and non-
parametric data were done using Pearson's and Spear-
man's rho tests respectively. p ≤ 0.05 was considered sig-
nificant.
Results
There were 62 patients who presented to the catheter
clinic for a change of the indwelling catheter over the 3 –
week period of the study. All the patients were males. The
mean age of the patients was 57.5 years (range 13 – 85
years). Fifty-two (83.9%) were married and 10 (16.1%)
were single before they started using the catheter. Thirty-
one patients (50%) had indwelling urethral catheter and
the other 31 (50%) used a suprapubic cystostomy cathe-
ter. Over this 3-week period, only 4 (6.5%) patients were
new clinic attendees. The other 58 (93.5%) patients had
attended the catheter clinic for a change of catheter more
than once. The mean duration of use of catheter was 23
months (range 0.5 – 72 months). There was no significant
difference in the duration of use of catheter between the
patients who used urethral catheter (mean 19.2 months)
and the patients who used suprapubic catheter (mean
23.5 months) {p = 0.412}. The patients changed their
catheters at a mean interval of 2.92 (± 1.08 SD) weeks.
The clinical diagnoses of these patients who attended the
catheter clinic are summarized in table 1. Forty (64.5%)
patients had a clinical diagnosis of benign prostatic hyper-
plasia (BPH) as the cause of the AUR and were awaiting
prostatectomy. Twenty-nine (72.5%) of these patients
Table 1: Aetiology of AUR in 62 patients
Clinical diagnosis N % Mean duration of 
catheter use (months)
BPH 40 64.0 20.4
Urethral trauma 16 28.4 23.7
Post-inflammatory stricture 5 6.0 23.2
Prostate cancer 1 1.6 --Page 2 of 4
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suprapubic cystostomy catheter. Of these patients, only
13 (32.5%) had ever had trial without catheter (TWOC)
carried out. There were 6 (46.2%) patients whose TWOC
was initially successful and the patients were able to void
after removal of the catheter. These six patients however
had a recurrence of the AUR within the next six months
and had to be re-catheterized. Urethral trauma was the
second commonest cause of AUR constituting 16 (25.8%)
of the patients. The patients developed urethral stricture
subsequently.
The side-effects that were associated with the prolonged
use of indwelling catheters are summarized in table 2.
Pain along the urethra or suprapubic pain associated with
presence of an indwelling catheter was the commonest
side-effect reported by the patients and occurred in 43
(69.4%) patients. The pain had a significant negative
impact on the patients' health-related QoL due to the
presence of an indwelling catheter. Thirty-nine (62.9%)
patients complained of loss of dignity associated with the
use of catheter. The complaint of loss of dignity did not
however significantly influence the overall health-related
QoL. Eighteen (29%) patients were either out of work or
out of school mainly because of pain from the indwelling
catheter (p = 0.004) or because they could not bear the
shame of wearing an indwelling catheter (p = 0.025).
Bleeding was a common side-effect among these patients
on prolonged use of indwelling catheter occurring in 20
(32.3%) patients. Inability to have sexual intercourse was
another major side-effect reported by the patients.
Twenty-three (37.1%) patients reported that lack of sexual
intercourse was a serious bother to them. This occurred
equally among the patients who used urethral or suprapu-
bic catheter (p = 0.496). Seven of these patients have been
deserted by their wives or sexual partners because of the
inability to perform satisfactory sexual intercourse. Peri-
catheter leakage of urine was reported by 10 (16.1%)
patients.
The average cost of change of catheter was estimated by
the patients. It must be noted that public health services
in Lagos State is highly subsidized. The mean cost of
change of indwelling catheter each time for the patient
was 789.67 Naira (range 460 – 2500 Naira). The service
charge paid in non-government hospitals in the same
environment for a change of indwelling bladder catheter
averages 5,000.00 Naira. This is however covered by the
government subsidy on health care among patients seen
in our hospital. Therefore, for a change of catheter in each
patient, it would cost between 5,460.67 Naira to 7500.00
Naira if they were to pay the service charge as well. The
total cost for the change of catheter for all 62 patients over
3 weeks was 109,032.00 Naira (or 424,038.00 Naira when
the service charge would be added). Extrapolating the cost
for 1 year, this would amounts to 1,890,000.00 Naira as
cost borne by the patients and 5,460,000.00 Naira as the
service charge covered by the subsidy from the govern-
ment. A total of 7,350,000.00 Naira would therefore be
the cost per year to change indwelling bladder catheter
among patients who had acute urinary retention in our
hospital while awaiting definitive surgery. This is equiva-
lent to 58,800 US dollars per annum.
The patients were asked to describe how they feel about
their life regarding the need to use a catheter for a pro-
longed period while awaiting surgery as ''sad", ''indiffer-
ent" or ''happy". Fifty-three (85.5%) patients described
that they were sad, 6 (9.7%) were indifferent and 3 (4.8%)
patients were happy. Overall, there was a significant cor-
relation between the patient's perceived health-related
QoL and the presence of pain in the suprapubic area or
along the urethra associated with the indwelling catheter
(p = 0.015 Spearman's rho test). Furthermore, when only
patients with BPH were considered, pain (p = 0.049) and
bleeding (p = 0.042) had a significant negative impact on
the health-related QoL.
Discussion and conclusion
AUR, a common urological emergency, is for the patient a
dreaded consequence of the progression of lower urinary
tract symptoms (LUTS). AUR contributes significantly to
the QoL of the patients with LUTS [1]. It is usually man-
aged by immediate urethral or suprapubic catheterization.
Patients who fail a trial without catheter (TWOC) follow-
ing AUR are usually planned to have definitive surgical
treatment [2].
In the more developed parts of the world, patients who
fail TWOC after AUR have an average catheterization time
of 12 days before the definitive surgical procedures are
carried out [4]. This is a far cry from the result of this study
that reveals an average catheterization time of 23 months
and majority of these patients would still wait for more
time before having surgery. A study in Ibadan, Nigeria






Pain 43 (69.4) 0.015, 0.049*
Bleeding 20 (32.3) 0.170, 0.042*
Loss of dignity 23 (37.1) 0.805
No sexual intercourse 23 (37.1) 0.451
Out of work or school 18 (29.0) 0.764
Pericatheter leakage of urine 10 (16.1) 0.567
Recurrent symptomatic UTI 3 (4.8) 0.474
QoL = Quality of life, UTI = urinary tract infection, *BPH patients onlyPage 3 of 4
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also shows a similar prolonged waiting time before sur-
gery in patients with BPH [3]. The duration of catheteriza-
tion in the study ranged from 1 to 13 months with a mean
of 8 months. Catheter-associated complications occurred
in 37.5% of patients in this particular study in Ibadan [3].
This underscores not only the need for more operation
time for urologic procedure to be made available in our
public hospitals but also the need to have more urologists
to serve the teaming population of urological patients in
the public hospitals of Lagos, Nigeria. It is common
knowledge that patients who have the financial power to
afford the treatment in the non-government hospitals in
Lagos would not need to have these prolonged catheteri-
zation and waiting time. Therefore, it is possible that
when the National Health Insurance Policy becomes fully
operational, more patients may be able to afford treat-
ment in the non-government hospital. This may then lead
to a lot of the pressures being taken off the public hospital
by patients who may not ordinarily be able to afford treat-
ment in the non-government hospital setting.
Prolonged use of indwelling catheter is accompanied by
several side-effects and complications [4, 5] as also dem-
onstrated by this study. Complications or side-effects
occurred in 95% of patients following prolonged use of
indwelling catheter after AUR. Most patients would have
urethral and/or suprapubic pain, occurring in 69% of
patients. Bleeding is also a common complication espe-
cially in patients with benign prostatic hyperplasia. In
addition to the fact that most patients (85.5%) described
that they are sad with their life, we also found that the rea-
son for the sadness is often because of pain and bleeding
associated with the prolonged use of indwelling catheter.
Furthermore, the cost implication of having an indwelling
bladder catheter is enormous as revealed in this study. In
addition to the huge subsidy that is given by the state gov-
ernment, the need to regularly change the indwelling
catheter is a huge financial burden to majority of these
patients. It is clearly evident that a considerable savings in
resources could be achieved if catheterization time after
AUR is reduced.
In conclusion, AUR is not only a painful experience for
the patient, the need to wear an indwelling catheter for a
prolonged period while awaiting surgery is also accompa-
nied with pain in majority of the patients. The prolonged
use of an indwelling catheter in addition to its huge finan-
cial burden also has several other complications and sig-
nificantly contributes to patients' poor QoL. Measures
that would significantly reduce the catheterization time
and consequently the waiting time for surgery will there-
fore be highly desirable.
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